ENVIROMED: Next generation toolbox for greener pharmaceuticals design and manufacturing
Stephanos Camarinopoulos and Michael explain how ENVIROMED project is reducing the environmental impact of medicines.
Filter by:
Stephanos Camarinopoulos and Michael explain how ENVIROMED project is reducing the environmental impact of medicines.
Christian Stevens, coordinator of our sister project TransPharm, explains all about TransPharm and its objective: moving towards a sustainable pharmaceutical industry.
Video explainer about IMPACTIVE, a European Union-funded project working to make mechanochemistry a reality in pharmaceutical settings.
This video introduces IMPACTIVE, a European Union-funded project working to make mechanochemistry a practical reality for pharmaceutical applications.
This article explores what APIs are, why are they important, and the strict regulations they face to ensure their quality and safety in pharmaceutical production worldwide.
Mechanochemical amide coupling enables the efficient synthesis and functionalisation of amides, including the first mechanochemical synthesis of imatinib.
This paper reports the use of mechanochemical processes in batch to prepare kilogram-scale of Ibuprofen-Nicotinamide co-crystal in an industrial eccentric vibration mill.
Author(s): Carlos Fernández and IMPACTIVE.
Carlos Fernández, scientific leader at the European project ETERNAL, explains all about this project and its objective: the reduction of the environmental impact of pharmaceutical products throughout their entire life cycle. This webinar is part of the IMPACTIVE webinar, which explores mechanochemistry, green pharmaceuticals, and green chemistry.
Author(s): Evelina Colacino and IMPACTIVE.
The first edition of the IMPACTIVE webinar series, featuring Evelina Colacino, IMPACTIVE project coordinator. In it, she explains all about the project and how mechanochemistry can help address shortages in the European pharmaceutical supply chain.
Author: Sanità 33.
Evelina Colacino, IMPACTIVE project coordinator, is interviewed by the Italian media outlet Sanità 33. The discussion focuses on pharmaceutical sustainability, specifically on pharmaceutical synthesis and her work on developing molecules without the use of solvents.